HEICO Contract Assets decreased by 2.0% to $116.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $118.21M to $116.90M. Over 5 years (FY 2020 to FY 2025), Contract Assets shows an upward trend with a 14.6% CAGR.
An increase indicates growing service-based revenue streams or complex commercialization contracts, while a decrease suggests the conversion of these assets into billed receivables.
This represents the company's right to consideration in exchange for goods or services that have been transferred to a c...
Common in companies providing value-added services to pharmaceutical manufacturers beyond simple distribution.
other_contract_with_customer_asset_gross_current| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.88M | $62.40M | $80.07M | $82.24M | $79.60M | $86.53M | $93.98M | $101.54M | $103.45M | $102.83M | $111.70M | $108.89M | $110.16M | $104.41M | $112.24M | $118.21M | $124.68M | $132.96M | $119.26M | $116.90M |
| QoQ Change | — | +4.2% | +28.3% | +2.7% | -3.2% | +8.7% | +8.6% | +8.0% | +1.9% | -0.6% | +8.6% | -2.5% | +1.2% | -5.2% | +7.5% | +5.3% | +5.5% | +6.6% | -10.3% | -2.0% |
| YoY Change | — | — | — | — | +32.9% | +38.7% | +17.4% | +23.5% | +30.0% | +18.8% | +18.9% | +7.2% | +6.5% | +1.5% | +0.5% | +8.6% | +13.2% | +27.3% | +6.3% | -1.1% |